ripekg:evaluation/RIPEAAAD6F9051C284833 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
prov:startedAtTime |
2026-03-08T13:19:46.441923Z |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEAAAD6F9051C284833 |
ripekg:publication-details/RIPEAAAD6F9051C284833Effect of sodium-glucose cotransporter-2 inhibitor on metabolic syndrome in people with prediabetes and obesity: A systematic review and meta-analysis |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
ripekg:registry-evidence/RIPEAAAD6F9051C284833 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |
ripekg:study-design-evidence/RIPEAAAD6F9051C284833 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAAAD6F9051C284833 |